Abstract:Xiaoyan Sai, &ast Chu Qin, &ast Zixiao Zhang, &ast Haoda Yu, Tao Bian Department of Respiratory Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, 214000, People's Republic of China &astThese authors contributed equally to this work Correspondence: Haoda Yu, Department of Respiratory Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, 214000, People's Republic of China, Email Tao Bian, Department of Respiratory Medicine, Wuxi People's Hospital Affiliated to Nanjing Medical University, Wuxi People's Hospital, Wuxi Medical Center, Nanjing Medical University, Wuxi, Jiangsu, 214000, People's Republic of China, Email Background: This study sought to explore the underlying mechanism of miR-21 mediated apoptosis and inflammation in chronic obstructive pulmonary disease (COPD) induced by cigarette smoke (CS). Methods: We detected levels and PTEN/Akt/NF-κB axis protein levels in peripheral lung tissues of COPD patients and CS-exposed mice and HBE cells. Western blotting assay was used to determine the expression of cleaved caspase-3. IL-6 and IL-8 protein was detected in cell supernatant from cells by ELISA. HBE cells were transfected with a miR-21 inhibitor, and co-culture with A549. Results: Increased miR-21 expression, reduced PTEN expression and following activation of Akt in in peripheral lung tissues of COPD patients and CS-exposed mice and HBE cells. Inhibition of miR-21 showed enhanced PTEN levels and reduced the expression of phosphorylated form of Akt and NF-κB. Decreased expression of cleaved caspase-3, IL-6 and IL-8 in A549 cells co cultured with HBE cells transfected with miR-21 inhibitor compared with transfected with miR-21 control inhibitor. Conclusion: MiR-21 contributes to COPD pathogenesis by modulating apoptosis and inflammation through the PTEN/Akt/NF-κB pathway. Targeting miR-21 may increase PTEN expression and inhibit Akt/NF-κB pathway, offering potential diagnostic and therapeutic value in COPD management. Keywords: COPD, miR-21, PTEN/Akt/NF-κB axis, apoptosis, inflammation Chronic obstructive pulmonary disease (COPD) represents a significant global health challenge, contributing extensively to morbidity, mortality, and healthcare utilization. Primarily induced by cigarette smoking, 1,2 COPD is marked by persistent oxidative stress and inflammation, culminating in irreversible airflow restriction due to the narrowing of small airways and the development of lung emphysema. 3,4 Currently, there are no definitive treatments to halt COPD progression, largely attributable to an incomplete understanding of its pathogenic mechanisms. Continuous exposure to deleterious particles or gases, particularly those found in tobacco smoke, is recognized as a primary factor in intensifying inflammatory responses. 5 For nearly all smokers, this starts with inflammation on the periphery of the airways and eventually spreads throughout the entire airway, causing a rapid loss of lung function. 6 The main cause of chronic inflammation is immune cell infiltration into the small airways, which may lead to airway remodeling and blockage. Chronic inflammation produces inflammatory mediators and damaging enzymes. 7,8 When a cell responds to environmental stimuli, which includes DNA damage and oxidative stress, it is said to be undergoing apoptosis. 9 According to a study conducted by Demedts et al 10 lung structural cell death may be a significant upstream event in the pathogenesis of COPD. CS triggers an excessive production of ROS in lung tissues, disrupting the balance between oxidative and antioxidant systems. This imbalance leads to cellular dysfunction and triggers apoptosis. 2,11,12 Individuals with COPD have more apoptotic alveolar epithelial cells in their lungs. The growth of structural cells is unable to counteract these pathological alterations, which results in the degeneration of lung tissue and the development of emphysema. 12 The mechanisms underlying COPD have not been fully elucidated. Several studies suggest that microRNAs (miRs), including miR-21, may significantly influence the pathogenesis of COPD. 13 Research indicates a correlation between miR-21 and the activation as well as the severity of the inflammatory response. 14,15 Prior studies have demonstrated an elevated expression of miR-21 in peripheral serum, mononuclear cells of COPD-afflicted rats and COPD patients. 16,17 Furthermore, research by He et al identified t -Abstract Truncated-

Reduced miR-146a Increases Prostaglandin E<sub>2</sub> in Chronic Obstructive Pulmonary Disease Fibroblasts

Reduced MicroRNA-146a Increases Prostaglandin E2 In Chronic Obstructive Pulmonary Disease Fibroblasts

Reduced Microrna-503 Expression Augments Lung Fibroblast VEGF Production in Chronic Obstructive Pulmonary Disease.

miR‐186‐5p regulates the inflammatory response of chronic obstructive pulmonary disorder by targeting HIF‐1α

Attenuation of inhibitory prostaglandin E2 signaling in human lung fibroblasts is mediated by phosphodiesterase 4.

MiR-1307-5p enhances fibroblast transdifferentiation to exacerbate chronic obstructive pulmonary disease through regulating FBXL16/HIF1α axis

MicroRNA mediated suppression of airway lactoperoxidase by TGF-β1 and cigarette smoke promotes airway inflammation

Angiotensin-converting Enzyme Defines Matrikine-Regulated Inflammation and Fibrosis

Gene Expression Networks in COPD: Microrna and Mrna Regulation

MicroRNA-377-3p exacerbates chronic obstructive pulmonary disease through suppressing ZFP36L1 expression and inducing lung fibroblast senescence

Reduced miR-513a-5p expression in COPD may regulate airway mucous cell hyperplasia through TFR1-dependent signaling

Late-Breaking Abstract: Mir-877 and Its Target Protein Hdac6 Are Involved in Airway Inflammation

OSGIN1 Regulates PM2.5-induced 2.5-Induced Fibrosis Via Mediating Autophagy in an in Vitro Model of COPD

OSGIN1 regulates PM2.5-induced fibrosis via mediating autophagy in an in vitro model of COPD

Impacts of anti-inflammatory phosphodiesterase inhibitors on a murine model of chronic pulmonary inflammation

AIM2 Inflammasome Activation Leads to IL-1α and TGF-β Release From Exacerbated Chronic Obstructive Pulmonary Disease-Derived Peripheral Blood Mononuclear Cells

A miRNA-21-Mediated PTEN/Akt/NF-κB Axis Promotes Chronic Obstructive Pulmonary Disease Pathogenesis

Role of the Fungus Pneumocystis in IL1β Pathway Activation and Airways Collagen Deposition in Elastase-Induced COPD Animals

Inhibition of Micro‐RNA 146a Expression in Lung Fibroblasts by Fluticasone Propionate, Salmeterol Xinafoate, and Related Agents

Microsomal Prostaglandin E Synthase-1 Deficiency Exacerbates Pulmonary Fibrosis Induced by Bleomycin in Mice.

MiR-344b-1-3p targets TLR2 and negatively regulates TLR2 signaling pathway